Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Otogenic Meningitis: A Comparison of Diagnostic Performance of Surgery and Radiology.

Bruschini L, Fortunato S, Tascini C, Ciabotti A, Leonildi A, Bini B, Giuliano S, Abbruzzese A, Berrettini S, Menichetti F; GISA (Italian Group for Antimicrobial Stewardship) Meningitis Study Group.

Open Forum Infect Dis. 2017 Apr 6;4(2):ofx069. doi: 10.1093/ofid/ofx069. eCollection 2017 Spring.

2.

Oral gentamicin therapy for Carbapenem-resistant Klebsiella pneumoniae gut colonization in hematologic patients: a single center experience.

Lambelet P, Tascini C, Fortunato S, Stefanelli A, Simonetti F, Vettori C, Leonildi A, Menichetti F.

New Microbiol. 2017 Jul;40(3):161-164. Epub 2017 May 17.

3.

Fungicidal activity and PK/PD of caspofungin as tools to guide antifungal therapy in a fluconazole-resistant C. parapsilosis candidemia.

Tascini C, Sozio E, Di Paolo A, Tintori G, Leonildi A, Bertolino G, Carmassi F, Tagliaferri E, Menichetti F, Barchiesi F.

J Chemother. 2017 Dec;29(6):376-379. doi: 10.1080/1120009X.2017.1289308. Epub 2017 Feb 15.

PMID:
28198656
4.

Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts.

Corte L, Roscini L, Colabella C, Tascini C, Leonildi A, Sozio E, Menichetti F, Merelli M, Scarparo C, Meyer W, Cardinali G, Bassetti M.

Sci Rep. 2016 Jun 1;6:26860. doi: 10.1038/srep26860.

5.

First Case of Trichoderma longibrachiatum CIED (Cardiac Implantable Electronic Device)-Associated Endocarditis in a Non-immunocompromised Host: Biofilm Removal and Diagnostic Problems in the Light of the Current Literature.

Tascini C, Cardinali G, Barletta V, Di Paolo A, Leonildi A, Zucchelli G, Corte L, Colabella C, Roscini L, Consorte A, Pasticci MB, Menichetti F, Bongiorni MG.

Mycopathologia. 2016 Apr;181(3-4):297-303. doi: 10.1007/s11046-015-9961-7. Epub 2015 Nov 20. Review.

PMID:
26588923
6.

Oral administration of gentamicin for prophylaxis of KPC-producing Klebsiella pneumoniae gut colonization in patients treated with a novel parenchymal-sparing liver surgery: the GEN Gut study.

Tascini C, Urbani L, Sbrana F, Forfori F, Licitra G, Leoni C, Balestri R, Rossi E, Fortunato S, Leonildi A, Puccini M, Di Paolo A, Ripoli A, Colombatto P, Menichetti F, Buccianti P.

Intensive Care Med. 2016 Jan;42(1):124-5. doi: 10.1007/s00134-015-4049-x. Epub 2015 Sep 21. No abstract available.

PMID:
26392255
7.

[Histoplasmosis: the multiple sides of an uncommon disease].

Amadori F, Doria R, Gemignani G, Flammini S, Leonildi A, Ciancia EM, Sanguinetti M, Menichetti F.

Infez Med. 2015 Mar;23(1):61-8. Italian.

8.

Easy synergism for colistin-resistant KPC-producing Klebsiella pneumoniae: the E-test with supplemented agar.

Tagliaferri E, Tascini C, Leonildi A, Ciullo I, Amadori F, Menichetti F.

Clin Microbiol Infect. 2015 Feb;21(2):e7-8. doi: 10.1016/j.cmi.2014.08.016. Epub 2014 Oct 12. No abstract available.

9.

Arterial blood culture to hasten the diagnosis of candidemia in critically ill patients.

Tascini C, Sbrana F, Cardinali G, Ripoli A, Leonildi A, Amadori F, Menichetti F.

Intensive Care Med. 2014 Jul;40(7):1059-60. doi: 10.1007/s00134-014-3336-2. Epub 2014 May 16. No abstract available.

PMID:
24832566
10.

Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: relevance of concomitant systemic antibiotic therapy.

Tascini C, Sbrana F, Flammini S, Tagliaferri E, Arena F, Leonildi A, Ciullo I, Amadori F, Di Paolo A, Ripoli A, Lewis R, Rossolini GM, Menichetti F; GENGUT Study Group.

Antimicrob Agents Chemother. 2014;58(4):1972-6. doi: 10.1128/AAC.02283-13. Epub 2014 Jan 13.

11.

Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae.

Tascini C, Tagliaferri E, Giani T, Leonildi A, Flammini S, Casini B, Lewis R, Ferranti S, Rossolini GM, Menichetti F.

Antimicrob Agents Chemother. 2013 Aug;57(8):3990-3. doi: 10.1128/AAC.00179-13. Epub 2013 Jun 10.

12.

Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit.

Sbrana F, Malacarne P, Viaggi B, Costanzo S, Leonetti P, Leonildi A, Casini B, Tascini C, Menichetti F.

Clin Infect Dis. 2013 Mar;56(5):697-700. doi: 10.1093/cid/cis969. Epub 2012 Nov 15.

PMID:
23155147
13.

Micafungin for Candida albicans pacemaker-associated endocarditis: a case report and review of the literature.

Tascini C, Bongiorni MG, Tagliaferri E, Di Paolo A, Flammini S, Soldati E, Leonildi A, Di Cori A, Menichetti F.

Mycopathologia. 2013 Feb;175(1-2):129-34. doi: 10.1007/s11046-012-9591-2. Epub 2012 Oct 17. Review.

PMID:
23073824
14.

Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.

Tascini C, Flammini S, Leonildi A, Ciullo I, Tagliaferri E, Menichetti F.

J Chemother. 2012 Aug;24(4):187-90. doi: 10.1179/1973947812Y.0000000026.

PMID:
23040680
15.

Susceptibility of Streptococcus pneumoniae clinical isolates to quinolones.

Tascini C, Leonildi A, Ciullo I, Flammini S, Tagliaferri E, Menichetti F.

J Chemother. 2012 Jun;24(3):185-6. doi: 10.1179/1973947812Y.0000000003. No abstract available.

PMID:
22759766
16.

Rapid detection of intestinal carriage of Klebsiella pneumoniae producing KPC carbapenemase during an outbreak.

Giani T, Tascini C, Arena F, Ciullo I, Conte V, Leonildi A, Menichetti F, Rossolini GM.

J Hosp Infect. 2012 Jun;81(2):119-22. doi: 10.1016/j.jhin.2012.04.004. Epub 2012 May 3.

PMID:
22559988
17.

Cardiovascular implantable electronic device endocarditis treated with daptomycin with or without transvenous removal.

Tascini C, Bongiorni MG, Di Cori A, Di Paolo A, Polidori M, Tagliaferri E, Fondelli S, Soldati E, Ciullo I, Leonildi A, Danesi R, Coluccia G, Menichetti F.

Heart Lung. 2012 Nov-Dec;41(6):e24-30. doi: 10.1016/j.hrtlng.2012.02.002. Epub 2012 Mar 20.

18.

Microbiology of cardiac implantable electronic device infections.

Bongiorni MG, Tascini C, Tagliaferri E, Di Cori A, Soldati E, Leonildi A, Zucchelli G, Ciullo I, Menichetti F.

Europace. 2012 Sep;14(9):1334-9. doi: 10.1093/europace/eus044. Epub 2012 Mar 7.

PMID:
22399202
19.

Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy.

Tascini C, Piaggesi A, Tagliaferri E, Iacopi E, Fondelli S, Tedeschi A, Rizzo L, Leonildi A, Menichetti F.

Diabetes Res Clin Pract. 2011 Oct;94(1):133-9. doi: 10.1016/j.diabres.2011.07.017. Epub 2011 Aug 6.

PMID:
21824673
20.

Vancomycin-resistant Enterococcus faecium (VRE) bacteremia in infective endocarditis successfully treated with combination daptomycin and tigecycline.

Polidori M, Nuccorini A, Tascini C, Gemignani G, Iapoce R, Leonildi A, Tagliaferri E, Menichetti F.

J Chemother. 2011 Aug;23(4):240-1. No abstract available.

PMID:
21803704
21.

Daptomycin blood concentrations and clinical failure: case report.

Tascini C, Tagliaferri E, Leonildi A, DI Lonardo A, Lambelet P, DI Paolo A, Menichetti F.

J Chemother. 2011 Aug;23(4):238-9. No abstract available.

PMID:
21803703
22.

Linezolid for endocarditis: a case series of 14 patients.

Tascini C, Bongiorni MG, Doria R, Polidori M, Iapoce R, Fondelli S, Tagliaferri E, Soldati E, Di Paolo A, Leonildi A, Menichetti F.

J Antimicrob Chemother. 2011 Mar;66(3):679-82. doi: 10.1093/jac/dkq506. Epub 2011 Jan 11. No abstract available.

PMID:
21393234
23.

Administration interval and daptomycin toxicity: a case report of rhabdomyolysis.

Sbrana F, Di Paolo A, Pasanisi EM, Tagliaferri E, Arvia C, Puntoni M, Leonildi A, Bigazzi F, Danesi R, Rovai D, Tascini C, Menichetti F.

J Chemother. 2010 Dec;22(6):434-5. No abstract available.

PMID:
21303756
24.

Cellulitis caused by a methicillin-sensitive Staphylococcus aureus isolate harboring Panton-Valentine toxin in an American soldier returning from Iraq.

Tascini C, Tagliaferri E, Rossolini GM, Mantengoli E, Mirarchi G, Leonildi A, Polidori M, Menichetti F.

Int J Dermatol. 2011 Feb;50(2):206-7. doi: 10.1111/j.1365-4632.2010.04456.x. No abstract available.

PMID:
21244388
25.

[In vitro synergism of ulifloxacin plus piperacillin/tazobactam against clinical isolates of Enterobacteriaceae producing extended-spectrum or AmpC-type β-lactamases].

Tascini C, Mantengoli E, Geminiani G, Leonildi A, Di Maggio T, Fondelli S, Rossolini GM, Tagiaferri E, Menichetti F.

Infez Med. 2010 Dec;18(4):243-7. Italian.

26.

111In-DTPA-Biotin uptake by Staphylococcus aureus.

Erba PA, Cataldi AG, Tascini C, Leonildi A, Manfredi C, Mariani G, Lazzeri E.

Nucl Med Commun. 2010 Nov;31(11):994-7. doi: 10.1097/MNM.0b013e32833ce32c.

PMID:
20827228
27.

A randomized controlled trial to examine the efficacy and safety of a new super-oxidized solution for the management of wide postsurgical lesions of the diabetic foot.

Piaggesi A, Goretti C, Mazzurco S, Tascini C, Leonildi A, Rizzo L, Tedeschi A, Gemignani G, Menichetti F, Del Prato S.

Int J Low Extrem Wounds. 2010 Mar;9(1):10-5. doi: 10.1177/1534734610361945.

PMID:
20207618
28.

Breakthrough Fusarium spp fungemia during caspofungin therapy in an ABO-incompatible orthotopic liver transplant patient.

Tascini C, Urbani L, Doria R, Catalano G, Leonildi A, Filipponi F, Menichetti F.

J Chemother. 2009 Apr;21(2):236-8. No abstract available.

PMID:
19423484
29.

Colistin in combination with rifampin and imipenem for treating a blaVIM-1 metallo-beta-lactamase-producing Enterobacter cloacae disseminated infection in a liver transplant patient.

Tascini C, Urbani L, Biancofiore G, Rossolini GM, Leonildi A, Gemignani G, Bindi ML, Mugnaioli C, Filipponi F, Menichetti F.

Minerva Anestesiol. 2008 Jan-Feb;74(1-2):47-9. Epub 2007 Dec 3.

30.

Activity of ulifloxacin against clinical hospital isolates.

Geminiani G, Tascini C, Leonildi A, Piaggesi A, Menichetti F.

Infez Med. 2007 Sep;15(3):169-73.

31.

Pacemaker endocarditis with pulmonary cavitary lesion due to Scedosporium prolificans.

Tascini C, Bongiorni MG, Leonildi A, Giannola G, Soldati E, Arena G, Doria R, Germenia C, Menichetti F.

J Chemother. 2006 Dec;18(6):667-9. No abstract available.

PMID:
17267349
32.

Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis.

Tascini C, Gemignani G, Palumbo F, Leonildi A, Tedeschi A, Lambelet P, Lucarini A, Piaggesi A, Menichetti F.

J Chemother. 2006 Dec;18(6):648-51.

PMID:
17267344
33.

Colistin, meropenem and rifampin in a combination therapy for multi-drug-resistant Acinetobacter baumannii multifocal infection. A case report.

Biancofiore G, Tascini C, Bisà M, Gemignani G, Bindi ML, Leonildi A, Giannotti G, Menichetti F.

Minerva Anestesiol. 2007 Mar;73(3):181-5. Epub 2006 Dec 12.

34.

Clinical and microbiological efficacy of colistin therapy in combination with rifampin and imipenem in multidrug-resistant Pseudomonas aeruginosa diabetic foot infection with osteomyelitis.

Tascini C, Menichetti F, Gemignani G, Palumbo F, Leonildi A, Tedeschi A, Piaggesi A.

Int J Low Extrem Wounds. 2006 Sep;5(3):213-6.

PMID:
16928678
35.
36.

Management of cardiac device infections: A retrospective survey of a non-surgical approach combining antibiotic therapy with transvenous removal.

Tascini C, Bongiorni MG, Gemignani G, Soldati E, Leonildi A, Arena G, Doria R, Giannola G, La Pira F, Tagliaferri E, Caravelli P, Dell'Anna R, Menichetti F.

J Chemother. 2006 Apr;18(2):157-63.

PMID:
16736884
38.

Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections.

Tascini C, Gemignani G, Ferranti S, Tagliaferri E, Leonildi A, Lucarini A, Menichetti F.

J Chemother. 2004 Jun;16(3):282-7.

PMID:
15330326
39.

Ex-vivo synergism: a method for optimizing antimicrobial combinations for difficult-to-treat enterococcal endocarditis.

Tascini C, Gemignani G, Leonildi A, Menichetti F.

J Chemother. 2003 Dec;15(6):613-5. No abstract available.

PMID:
14998090
40.

Caspofungin in combination with itraconazole and amphotericin B for the treatment of invasive Aspergillosis in humans, with a method to test ex vivo synergism.

Tascini C, Tagliaferri E, Iapoce R, Leonildi A, Menichetti F.

Clin Microbiol Infect. 2003 Aug;9(8):901-2. No abstract available.

41.
42.

Classification of hepatitis C virus type 2 isolates by phylogenetic analysis of core and NS5 regions.

Pistello M, Maggi F, Fornai C, Leonildi A, Morrica A, Vaatteroni ML, Bendinelli M.

J Clin Microbiol. 1999 Jun;37(6):2116-7. No abstract available.

Supplemental Content

Loading ...
Support Center